A carregar...
Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
BACKGROUND: Multidrug resistance is responsible for the poor outcome in breast cancer therapy. Lapa is a novel therapeutic agent that generates ROS through the catalysis of the NAD(P) H:quinone oxidoreductase-1 (NQO1) enzyme which significantly facilitate the intracellular accumulation of the co-del...
Na minha lista:
| Publicado no: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047616/ https://ncbi.nlm.nih.gov/pubmed/30034236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S163929 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|